Quality of Life in Men With Locally Advanced Adenocarcinoma of the Prostate: An Exploratory Analysis Using Data From the CaPSURE Database

2008 ◽  
Vol 180 (6) ◽  
pp. 2409-2414 ◽  
Author(s):  
Wesley M. White ◽  
Natalia Sadetsky ◽  
W. Bedford Waters ◽  
Peter R. Carroll ◽  
Mark S. Litwin
Keyword(s):  
Quality Of Life ◽  
Locally Advanced ◽  
Exploratory Analysis ◽  
Adenocarcinoma Of The Prostate ◽  
Using Data

QUALITY OF LIFE AMONG MEN WITH LOCALLY ADVANCED ADENOCARCINOMA OF THE PROSTATE

2008 ◽  
Vol 179 (4S) ◽  
pp. 162-163
Author(s):  
Wesley M White ◽  
Natalia Sadetsky ◽  
W Bedford Waters ◽  
Peter R Carroll ◽  
Mark S Litwin
Keyword(s):  
Quality Of Life ◽  
Locally Advanced ◽  
Adenocarcinoma Of The Prostate

COMPARISON OF THE QUALITY OF LIFE OF PATIENTS IN THE LOCALY ADVANCED BREAST CANCER FORMS AFTER SYSTEM AND INTRALYMPHATIC POLYCHEMOTHERAPY

2018 ◽  
Vol 4 ◽  
pp. 3-13
Author(s):  
Yuriy Dumanskiy ◽  
Oleksandr Bondar ◽  
Oleksandr Tkachenko ◽  
Evhenii Stoliachuk ◽  
Vasilii Ermakov
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Locally Advanced ◽  
Developed Countries ◽  
Control Group ◽  
Preoperative Treatment ◽  
Discrete Elements ◽  
Important Indicator ◽  
Significant Difference

In recent years, breast cancer (BC) is the most common cancer pathology and the most common cause of disability among women in developed countries. Finding the most effective ways of interaction between the patient and the doctor creates the preconditions for the necessary analysis of the treatment process from an objective and subjective point of view. Therefore, an important indicator to be taken into account is the quality of life of a patient. To compare the indicators of a comprehensive assessment of the quality of life of patients to the adverse locally advanced forms (LA) of breast cancer before and after systemic intravenous polychemotherapy (SPCTx) and selective endolymphatic polychemotherapy (ELPCTx) in neoadjuvant mode. The study was conducted on the basis of a random analysis of outpatient cards from 112 patients with LA BC T4A-DN0-3M0 who received a comprehensive antitumor treatment on the basis of the Donetsk regional antitumor center and the University Clinic of the Odessa National Medical University from 2000 to 2017, which was proposed a questionnaire at various stages of preoperative treatment. The first (control) group consisted of 65 patients (58 %) with inoperable forms of LA BC, which was performed in neoadjuvant mode by SPCTx. The second (study group) included 47 patients (42 %) with inoperable forms of LA BC, which was performed as a neoadjuvant course ELPCTx. According to the integral indicators of quality of life and quality of health between patients in the control and study groups, there was no statistically significant difference. In a detailed analysis of the indicators of symptomatic scales, the difference between the groups did not exceed the critical. Based on the results of a study conducted among patients receiving endolymphatic chemotherapy in a neoadjuvant mode, the subjective evaluations of treatment in absolute numbers have better reference values without statistical superiority. The study of the integrative indicator of quality of life and its discrete elements is an ergonomic and economical means of heuristic assessment of the health of patients in order to further develop more rational and convenient ways of solving urgent issues of modern oncology by increasing compliance and finding a compromise between the physician and the patient.

Improving the Quality of Survey Data on College Campus Woman Abuse: The Contribution of a Supplementary Open-Ended Question

2020 ◽  
pp. 107780122097549
Author(s):  
Walter S. DeKeseredy ◽  
Danielle M. Stoneberg ◽  
James Nolan ◽  
Gabrielle L. Lory
Keyword(s):  
Quality Of Life ◽  
Higher Education ◽  
Survey Data ◽  
College Campus ◽  
Woman Abuse ◽  
Institutions Of Higher Education ◽  
Prevalence Rates ◽  
Methodological Challenge ◽  
Using Data

Obtaining accurate survey data on the prevalence of woman abuse in institutions of higher education continues to be a major methodological challenge. Underreporting is difficult to overcome; yet, there may be effective ways of minimizing this problem. One is adding a supplementary open-ended question to a primarily quantitative questionnaire. Using data derived from the Campus Quality of Life Survey (CQLS), this article examines whether asking respondents to complete such a question increases the prevalence rates of four types of woman abuse and provides information on behaviors that are not included in widely used and validated measures of these harms.

Impact of locally advanced or metastatic prostate cancer on the quality of life

2017 ◽  
Vol 41 (6) ◽  
pp. 368-375
Author(s):  
I. López-Calderero ◽  
L. López-Fando ◽  
E. Ríos-González ◽  
P. Maisonobe ◽  
E. Hernández-Yuste ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Metastatic Prostate Cancer ◽  
Locally Advanced

scholarly journals Patient-Reported Outcomes, Health-Related Quality of Life, and Clinical Outcomes for Urothelial Cancer Patients Receiving Chemo- or Immunotherapy: A Real-Life Experience

2021 ◽  
Vol 10 (9) ◽  
pp. 1852
Author(s):  
Gry Assam Taarnhøj ◽  
Henriette Lindberg ◽  
Christoffer Johansen ◽  
Helle Pappot
Keyword(s):  
Quality Of Life ◽  
Cancer Patients ◽  
Patient Reported Outcomes ◽  
Life Experience ◽  
Locally Advanced ◽  
Neoadjuvant Treatment ◽  
Real Life ◽  
Oncological Treatment ◽  
Patient Reported

Patients with urothelial cell carcinoma (UCC) often have comorbidities, which cause trouble for the completion of oncological treatment, and little is known about their quality of life (QoL). The aim of the present study was to obtain and describe patient-reported outcomes (PRO) and QoL data from UCC patients in the treatment for locally advanced muscle-invasive or metastatic UCC. A total of 79 patients with UCC completed four questionnaires (EORTC QLQ-C30, QLQ-BLM30, HADS, and select PRO-CTCAE™ questions) once weekly during their treatment. From those, 26 patients (33%) underwent neoadjuvant treatment for local disease while 53 patients (67%) were treated for metastatic disease. Of all patients, 54% did not complete the planned treatment due to progression, nephrotoxicity, death, or intolerable symptoms during treatment. The five most prevalent PRO-CTCAE grade ≥ 2 symptoms were frequent urination (37%), fatigue (35%), pain (31%), dry mouth (23%), and swelling of the arms or legs (23%). The baseline mean overall QoL was 61 (±SD 24) for all patients (neoadjuvant (73, ±SD 19) and metastatic (54, ±SD 24)) and remained stable over the course of treatment for both groups. A stable overall QoL was observed for the patients in this study. More than half of the patients did not, however, complete the planned treatment. Further supportive care is warranted for bladder cancer patients.

Sign in / Sign up

Export Citation Format

Share Document